Opioid Addiction

Latest

Buprenorphine for Substance Use Disorder: Is Certification Right for Your Practice?

By

Rachael Beairsto

There is enormous need for well-trained providers who are educated in treating opioid use disorder.

FDA, DEA Issue Joint Warning Letters to Illegal Online Opioid Sellers

By

Steve Duffy

The FDA and the Drug Enforcement Administration (DEA) have issued joint warning letters to several website operators that have been illegally selling opioid medications online.

Lofexidine May Effectively Mitigate Symptoms of Opioid Withdrawal Syndrome

By

Florence Chaverneff, PhD

Treatment with lofexidine may provide better control of the symptoms of opioid withdrawal syndrome compared with placebo.

eGFR Affects Risk for Opioid-Related Death, Hospitalization

Receipt of prescription opioids is associated with an increased risk for death and hospitalization, especially in patients with lower estimated glomerular filtration rates.

Adrenergic, Not Opioid Pathways, May Mediate Rapid Death From Fentanyl

By

Amit Akirov, MD

Fentanyl and fentanyl analogues may cause rapid death through airway compromise and severe muscle rigidity.

Johnson & Johnson Settles Opioid Suit With 2 Ohio Counties

With a federal trial pending, the pharmaceutical giant Johnson & Johnson agreed Wednesday to pay two Ohio counties more than $20 million for its role in the ongoing opioid crisis.

Disparities in Medication-Assisted Treatment Initiation for Opioid Use Disorder

By

Clinical Pain Advisor Contributing Writer

Medication-assisted treatment initiation for opioid use disorder was defined as a prescription of injectable naltrexone or buprenorphine which was recorded in an electronic health record.

USPSTF Finds Evidence Lacking to Prevent Illicit Drug Use in Youth

The U.S. Preventive Services Task Force (USPSTF) finds that the current evidence is insufficient to recommend primary care-based interventions to prevent illicit drug use in children, adolescents, and young adults.

Risks Associated With Discontinuation of Chronic Opioid Therapy for Pain

By

Tyler Rice

Discontinuing chronic opioid therapy for pain may not reduce mortality risk, and may be associated with an increased risk for overdose death.

Eight Touchpoints May Predict Opioid Overdoses

Eight candidate touchpoints are associated with increased risk of fatal opioid overdose.